| 93402-6 |
Cronobacter sakazakii DNA |
PrThr |
Bld.pos growth |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Cronobacter sakazakii DNA [Presence] by NAA with probe detection in Positive blood culture |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
93402-6 |
|
Probe.amp.tar |
|
|
Observation |
|
|
|
0 |
C sakazakii DNA Bld Pos Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; C sakazakii; C sakazakii DNA; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Enterobacter sakazakii; Enterobacteriaceae; Gram Negative Bacteria; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93403-4 |
Citrobacter sp DNA |
PrThr |
Bld.pos growth |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Citrobacter sp DNA [Presence] by NAA with probe detection in Positive blood culture |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
93403-4 |
|
Probe.amp.tar |
|
|
Observation |
|
|
|
0 |
Citrobac sp DNA Bld Pos Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Citrobac sp; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93404-2 |
Enterobacter cloacae complex DNA |
PrThr |
Bld.pos growth |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Enterobacter cloacae complex DNA [Presence] by NAA with probe detection in Positive blood culture |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
93404-2 |
|
Probe.amp.tar |
|
|
Observation |
|
|
|
0 |
E cloac comp DNA Bld Pos Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Compx; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E cloac comp; E. cloacae; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93405-9 |
Bacteroides fragilis DNA |
PrThr |
Bld.pos growth |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Bacteroides fragilis DNA [Presence] by NAA with probe detection in Positive blood culture |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
93405-9 |
|
Probe.amp.tar |
|
|
Observation |
|
|
|
0 |
B fragilis DNA Bld Pos Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B fragilis; B fragilis DNA; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93406-7 |
Acinetobacter baumannii DNA |
PrThr |
Bld.pos growth |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Acinetobacter baumannii DNA [Presence] by NAA with probe detection in Positive blood culture |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
93406-7 |
|
Probe.amp.tar |
|
|
Observation |
|
|
|
0 |
A baumannii DNA Bld Pos Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; A baumannii; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93407-5 |
Gram negative blood culture panel |
- |
Bld.pos growth |
Pt |
- |
Probe.amp.tar |
|
ACTIVE |
Gram negative blood culture panel by NAA with probe detection in Positive blood culture |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
93407-5 |
|
Probe.amp.tar |
|
|
Order |
|
|
|
0 |
GN Bld Culture Pnl Bld Pos NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; GN Bld Culture Pnl; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; NEG; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood |
2.67 |
2.67 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 93408-3 |
Platelet aggregation.epinephrine induced^10 umol/L |
RelACnc |
PRP |
Pt |
Qn |
|
|
ACTIVE |
Platelet aggregation EPINEPHrine induced in Platelet rich plasma --10 umol/L |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
COAG |
|
93408-3 |
|
|
|
|
Both |
|
|
|
0 |
PA Epineph 10 umol/L PRP |
|
|
|
|
|
Adrenalin; Adrenaline; Adreneline; Agg; Aggr; COAGULATION; E; Epi; Epin; Epinep; Epineph; Epinphrine; Eppi; Left; Levo; PA; PA Epineph; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes |
2.67 |
2.67 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 93409-1 |
Platelet aggregation.epinephrine induced^5 umol/L |
RelACnc |
PRP |
Pt |
Qn |
|
|
ACTIVE |
Platelet aggregation EPINEPHrine induced in Platelet rich plasma --5 umol/L |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
COAG |
|
93409-1 |
|
|
|
|
Both |
|
|
|
0 |
PA Epineph 5 umol/L PRP |
|
|
|
|
|
Adrenalin; Adrenaline; Adreneline; Agg; Aggr; COAGULATION; E; Epi; Epin; Epinep; Epineph; Epinphrine; Eppi; Left; Levo; PA; PA Epineph; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes |
2.67 |
2.67 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 9341-9 |
Cerebroside sulfatase |
MRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Cerebroside sulfatase [Mass/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
mg/24 H |
|
|
|
|
|
|
CHEM |
|
9341-9 |
|
|
|
|
Both |
|
|
|
0 |
Arylsulfatase A 24h Ur-mRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Aryl sulfatase A; Arylsulfatase A; Chemistry; Mass Rate; Metachromatic leucodystrophy; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urn |
2.7 |
1.0i |
|
|
|
|
|
|
|
mg/(24.h) |
|
|
|
0 |
| 93410-9 |
Platelet aggregation.ristocetin induced^5 ug/mL |
RelACnc |
PRP |
Pt |
Qn |
|
|
ACTIVE |
Platelet aggregation ristocetin induced in Platelet rich plasma --5 ug/mL |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
COAG |
|
93410-9 |
|
|
|
|
Both |
|
|
|
0 |
PA Rist 5 ug/mL PRP |
|
|
|
|
|
Agg; Aggr; COAGULATION; mcg; PA; PA Rist; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RIPA; RlACnc; Thrombocyte; Thrombocytes |
2.67 |
2.67 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 93411-7 |
COMT gene product metabolic activity interpretation |
Imp |
Bld/Tiss |
Pt |
Ord |
Molgen |
|
ACTIVE |
COMT gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.PHARMG |
|
93411-7 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
COMT gene prod met activ Bld/T-Imp |
|
|
|
|
|
Activ; Actvty; Blood; Catechol-O-Methyltransferase; COMT gene prod met activ imp; Drug metabolism; Gene prod met act imp; HEL-S-98n; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Movements; Ordinal; PCR; Phenotype; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.68 |
2.67 |
|
|
|
|
|
|
|
|
|
|
Release 2.68: SCALE_TYP: Corrected since reported results are ordinal. |
0 |
| 93412-5 |
SLCO1B1 gene targeted mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
SLCO1B1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.PHARMG |
|
93412-5 |
|
Molgen |
|
|
Both |
|
|
|
0 |
SLCO1B1 Mut Anl Bld/T |
|
|
|
|
|
Blood; Document; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Mut; Mut Anl; Mutations; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93413-3 |
Mechanical circulatory support+consultation note |
Find |
{Setting} |
Pt |
Doc |
{Role} |
|
TRIAL |
Mechanical circulatory support Consultation note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
93413-3 |
|
{Role} |
|
|
Both |
|
|
|
0 |
MCS+consult note |
|
|
|
|
|
Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; MCS+consult note; notes; Point in time; Random; Visit note |
2.67 |
2.67 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 93414-1 |
Altered level of consciousness in last 3D |
Find |
^Patient |
3D |
Ord |
CAM.CMS |
|
ACTIVE |
Altered level of consciousness in last 3 day [CAM.CMS] |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CMS |
|
93414-1 |
|
CAM.CMS |
|
|
Observation |
|
|
|
0 |
|
|
CMS |
Altered level of consciousness - Did the patient have altered level of consciousness as indicated by any of the following criteria? Vigilant - startled easily to any sound or touch, Lethargic - repeatedly dozed off when being asked questions, but responded to voice or touch, Stuporous - very difficult to arouse and keep aroused for the interview, Comatose - could not be aroused |
|
|
3 days; Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93415-8 |
Disorganized thinking in last 3D |
Find |
^Patient |
3D |
Ord |
CMS Assessment |
|
DEPRECATED |
Deprecated Disorganized thinking in last 3 days [CMS Assessment] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CMS |
|
93415-8 |
|
CMS Assessment |
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey |
2.7 |
2.67 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 93416-6 |
Inattention in last 3D |
Find |
^Patient |
3D |
Nom |
CMS Assessment |
|
DEPRECATED |
Deprecated Inattention in last 3 days [CMS Assessment] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.CMS |
|
93416-6 |
|
CMS Assessment |
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Past; Survey |
2.7 |
2.67 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 93417-4 |
IRF-PAI v4.0, LCDS v5.00 - Signs and Symptoms of Delirium (from CAM) |
- |
^Patient |
3D |
- |
CMS Assessment |
|
DISCOURAGED |
IRF-PAI v4.0, LCDS v5.00 - Signs and Symptoms of Delirium (from CAM) [CMS Assessment] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.CMS |
|
93417-4 |
|
CMS Assessment |
|
|
Order |
|
|
|
0 |
|
|
|
|
|
|
3 days; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey; Sx |
2.69 |
2.67 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 93418-2 |
(8;8)(q13;q21)(HEY1,NCOA2) fusion transcript |
PrThr |
Tiss |
Pt |
Ord |
Molgen |
|
ACTIVE |
(8;8)(q13;q21)(HEY1,NCOA2) fusion transcript [Presence] in Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
93418-2 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
(8;8)(HEY1,NCOA2) Tiss Ql |
|
|
|
|
|
(8;8)(HEY1,NCOA2); DNA; gene fusion; gene translocation; Molecular genetics; Molecular pathology; MOLPATH; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; RNA; Screen; Tissue; Tissue, unspecified; translocation |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93419-0 |
Alpha 1 antitrypsin fecal clearance panel |
- |
Ser/Plas+Stool |
Pt |
Qn |
|
|
ACTIVE |
Alpha 1 antitrypsin fecal clearance panel - Serum or Plasma and Stool |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
93419-0 |
|
|
|
|
Order |
|
|
|
0 |
A1AT Cl Pnl SerPl+Stl |
|
|
|
|
|
A1; A1A; A1AT; A-1-AT; A1-AT; A1AT Cl Pnl; AAT; Alfa; Alpha-1-antitrypsin.total; Alpha-1-protease inhibitor; Alpha-1-proteinase inhibitor; Alpha-1-trypsin inhibitor; Bowel movement; Chemistry; Cl; Clear; Clearanc; Clearances; Clr; Faecal; Faeces; Fecal; Feces; i; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPl+Stl; SerPlas; Serum; Serum or plasma; Serum or plasma and stool; SR; Stl; Stool = Fecal |
2.67 |
2.67 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 9342-7 |
Cholesterol |
Prctl |
Ser/Plas |
Pt |
SemiQn |
|
|
ACTIVE |
Cholesterol [Percentile] |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
9342-7 |
|
|
|
|
Both |
|
|
|
0 |
Cholest Prctl SerPl |
|
|
|
Y |
|
Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; Lipid; Percentile; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR |
2.75 |
1.0i |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93420-8 |
APOA1 gene full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Sequencing |
|
ACTIVE |
APOA1 gene full mutation analysis in Blood or Tissue by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
93420-8 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
APOA1 Full Mut Anl Bld/T Seq |
|
|
|
|
|
Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; high-throughput sequencing; HTS; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 93421-6 |
Glial fibrillary acidic protein.alpha subunit Ab.IgG |
Titr |
CSF |
Pt |
SemiQn |
IF |
|
ACTIVE |
Glial fibrillary acidic protein alpha subunit IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
93421-6 |
|
IF |
|
|
Both |
|
|
|
0 |
GFAP alpha IgG Titr CSF IF |
|
|
|
|
|
ABS; Aby; ACIF; Alfa; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; GFAP; GFAP alpha; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Pituitary glycoproteins; Point in time; PR; Prot; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Stroke; TBI (Traumatic Brain Injury); Time Resolved Fluorescence; Titer; Titered; Titre; Traumatic Brain Injuries; TRF; Ttr |
2.75 |
2.67 |
|
|
|
|
|
|
|
{titer} |
|
|
Release 2.68: COMPONENT: Corrected Component since this test detects the alpha subunit of the glial fibrillary acidic protein. |
0 |
| 93422-4 |
Glial fibrillary acidic protein.alpha subunit Ab.IgG |
PrThr |
CSF |
Pt |
Ord |
CBA IFA |
|
ACTIVE |
Glial fibrillary acidic protein alpha subunit IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
93422-4 |
|
CBA IFA |
|
|
Both |
|
|
|
0 |
GFAP alpha IgG CSF Ql CBA IFA |
|
|
|
|
|
ABS; Aby; Alfa; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; GFAP; GFAP alpha; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Ordinal; Pituitary glycoproteins; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Stroke; TBI (Traumatic Brain Injury); Traumatic Brain Injuries |
2.69 |
2.67 |
|
|
|
|
|
|
|
|
|
|
Release 2.68: COMPONENT: Added "subunit" to the Component for consistency across terms. |
0 |
| 93423-2 |
Glial fibrillary acidic protein.alpha subunit Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Glial fibrillary acidic protein alpha subunit IgG Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
93423-2 |
|
IF |
|
|
Both |
|
|
|
0 |
GFAP alpha IgG Titr Ser IF |
|
|
|
|
|
ABS; Aby; ACIF; Alfa; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; GFAP; GFAP alpha; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Pituitary glycoproteins; Point in time; PR; Prot; Random; Serology; Serum; SmQn; SR; Stroke; TBI (Traumatic Brain Injury); Time Resolved Fluorescence; Titer; Titered; Titre; Traumatic Brain Injuries; TRF; Ttr |
2.75 |
2.67 |
|
|
|
|
|
|
|
{titer} |
|
|
Release 2.68: COMPONENT: Corrected Component since this test detects the alpha subunit of the glial fibrillary acidic protein. |
0 |
| 93424-0 |
Glial fibrillary acidic protein.alpha subunit Ab.IgG |
PrThr |
Ser |
Pt |
Ord |
CBA IFA |
|
ACTIVE |
Glial fibrillary acidic protein alpha subunit IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
93424-0 |
|
CBA IFA |
|
|
Both |
|
|
|
0 |
GFAP alpha IgG Ser Ql CBA IFA |
|
|
|
|
|
ABS; Aby; Alfa; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; GFAP; GFAP alpha; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Ordinal; Pituitary glycoproteins; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Stroke; TBI (Traumatic Brain Injury); Traumatic Brain Injuries |
2.69 |
2.67 |
|
|
|
|
|
|
|
|
|
|
Release 2.68: COMPONENT: Added "subunit" to Component name for consistency across terms. |
0 |
